News and Trends 21 Feb 2018
FDA Approves AstraZeneca’s Lung Cancer Treatment after Rejecting Merck and Pfizer’s
The FDA approval will give AstraZeneca a competitive advantage in the lung cancer treatment market over Merck KGaA & Pfizer, who received rejections for a similar treatment. AstraZeneca received FDA approval for…